TapewireFind a company

person · Reporting owner

YEUTTER CLAYTON K

Disclosed activity across 1 company

Tapewire entity
181088
SEC CIK
0001172569

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

NEOGEN CORP

Report date November 10, 2016 · Filed November 16, 2016

Section 16 reporting ended · disclosed 2016-11-16. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
common StockSEC Table I · non-derivativeDirect5,000 Reported balance After 2016-11-10 transaction · row 1
1 source row

Row 1 · 2016-11-10 · Exercise / conversion · Acquired 4,500 · Balance 5,000

Common StockSEC Table I · non-derivativeDirect500 Reported balance After 2016-11-10 transaction · row 2
1 source row

Row 2 · 2016-11-10 · Sale · Disposed 4,500 · Balance 500

Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.75 · Expires 2021-10-06Direct33,750 Reported balance After 2016-11-10 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2016-11-10 · Exercise / conversion · Disposed 4,500 · Balance 33,750

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 10, 2016 Filed Nov 16, 2016 00:01 UTC NEOGEN CORP NEOG · Entity 4338 Exercise / conversionCommon Stock (Right to Buy) · Derivative 4,500 $0.00 Strike: $22.75 $0.00
Disclosure

SEC source: 0000711377-16-000103 · primary_doc.xml · derivative · entry 3

YEUTTER CLAYTON K · CIK 0001172569 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,750

Underlying: Common Stock · 4,500 shares

Expires 2021-10-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2016 Filed Nov 16, 2016 00:01 UTC NEOGEN CORP NEOG · Entity 4338 SaleCommon Stock 4,500 $59.00 $265,500.00
Disclosure

SEC source: 0000711377-16-000103 · primary_doc.xml · nonDerivative · entry 2

YEUTTER CLAYTON K · CIK 0001172569 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500

Read SEC document
November 10, 2016 Filed Nov 16, 2016 00:01 UTC NEOGEN CORP NEOG · Entity 4338 Exercise / conversioncommon Stock 4,500 $22.75 $102,389.85
Disclosure

SEC source: 0000711377-16-000103 · primary_doc.xml · nonDerivative · entry 1

YEUTTER CLAYTON K · CIK 0001172569 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.